Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
62M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
51.4M
-
Shares change
-
-7.65M
-
Total reported value, excl. options
-
$178M
-
Value change
-
-$23.4M
-
Number of buys
-
56
-
Number of sells
-
-60
-
Price
-
$3.46
Significant Holders of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) as of Q3 2022
137 filings reported holding MGNX - MACROGENICS INC - Common Stock, par value $0.01 per share as of Q3 2022.
MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.4M shares
of 62M outstanding shares and own 82.89% of the company stock.
Largest 10 shareholders include Bellevue Group AG (7.33M shares), ARMISTICE CAPITAL, LLC (6.13M shares), VANGUARD GROUP INC (4.18M shares), MILLENNIUM MANAGEMENT LLC (3.54M shares), WASATCH ADVISORS INC (2.9M shares), T. Rowe Price Investment Management, Inc. (2.88M shares), Assenagon Asset Management S.A. (1.8M shares), FEDERATED HERMES, INC. (1.41M shares), STATE STREET CORP (1.38M shares), and Rock Springs Capital Management LP (1.21M shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.